⌘K
Loading ticker…
Alumis Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Alumis Inc. Common Stock (ALMS) has a 3-month relative strength percentile of 40 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 98. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.0%, relative volume 4.63×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
40 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
ALMS is in a stage 2 uptrend, week 2. Currently in a 83-day base; basing ADR 6.5% (broad 8.2%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 13.9% / 54.3%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Related searches
ALMS is held by 5 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $67M notional. Top 3 carry $123M.
Top 5 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $67M |
| IWMiShares Russell 2000 ETF | 0.05% | $37M |
| VXFVanguard Extended Market ETF | 0.02% | $20M |
| XPHState Street SPDR S&P Pharmaceuticals ETF | 1.60% | $5M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ALMS Jan avg: 73.15% median: 73.15% win: 50% σ: 110.28% n: 2 2024-07-01 → 2026-05-29 | ALMS Feb avg: -8.35% median: -8.35% win: 50% σ: 41.70% n: 2 2024-07-01 → 2026-05-29 | ALMS Mar avg: 3.12% median: 3.12% win: 50% σ: 40.90% n: 2 2024-07-01 → 2026-05-29 | ALMS Apr avg: -10.25% median: -10.25% win: 50% σ: 31.57% n: 2 2024-07-01 → 2026-05-29 | ALMS May avg: -13.99% median: -13.99% win: 0% σ: 2.08% n: 2 2024-07-01 → 2026-05-29 | ALMS Jun avg: -14.29% median: -14.29% win: 0% σ: 0.00% n: 1 2024-07-01 → 2026-05-29 (current) | ALMS Jul avg: 15.24% median: 15.24% win: 50% σ: 32.19% n: 2 2024-07-01 → 2026-05-29 | ALMS Aug avg: 7.66% median: 7.66% win: 100% σ: 6.24% n: 2 2024-07-01 → 2026-05-29 | ALMS Sep avg: -14.96% median: -14.96% win: 0% σ: 1.34% n: 2 2024-07-01 → 2026-05-29 | ALMS Oct avg: 12.52% median: 12.52% win: 100% σ: 9.23% n: 2 2024-07-01 → 2026-05-29 | ALMS Nov avg: 21.64% median: 21.64% win: 50% σ: 56.34% n: 2 2024-07-01 → 2026-05-29 | ALMS Dec avg: 6.07% median: 6.07% win: 50% σ: 29.96% n: 2 2024-07-01 → 2026-05-29 |